Get Started with NeoGenomics
IHC & ISH
NeoTYPE® Cancer Profiles
The NeoTYPE Next-Gen Cancer-Specific Profiles are the first set of targeted molecular profiles designed to detect genomic alterations in clinically significant driver genes based on multi-method detection techniques centered primarily on next-gen sequencing. This highly-focused approach encompasses the ability to detect clinically actionable mutations in genes recommended for testing by the CAP/AMP Guidelines, current literature and clinical trials related to specific hematological and solid tumor cancers.
In addition, the NeoTYPE™ Next-Gen Cancer-Specific Profiles offer our pathology clients the unique opportunity to perform Tech-Only FISH in the majority of Profiles, which gives them enhanced ordering flexibility. Testing with the NeoTYPE™ Profiles eliminates the complexity of molecular profiling and simplifies your ability to obtain comprehensive actionable solutions to suit all your needs.
These Profiles offer a targeted approach to understanding the disease biology and establish a platform for assessing the diagnosis, determining prognosis, and assisting in the therapy selection process.
NeoTYPE Solid Tumor Profiles are designed to provide precise characterization of actionable driver mutations important in that specific tumor. The reduced DNA requirements of NGS coordinate well with fine needle biopsy and other minute sample sizes that sometimes limit solid tumor analysis
Head & Neck
Other Solid Tumor